The business model for bringing lucrative new pharmaceutical drugs to market includes very robust marketing budgets, and 9 out of 10 pharmaceutical companies spend more on advertising than they do on research.
And why not?
Americans spend an average of $1000 per person, per year on pharmaceutical drugs.
The effort to capture these dollars is leading more companies to fast track or even fabricate the research involved in bringing a new drug to market.
Here’s a look at how much the largest pharmaceutical companies spent on marketing vs. expenditures on research and development in 2013:
The push to push drugs on the American people is heavily dependent on the ability to produce favorable research that backs any and all claims that marketing departments wish to make about the drug in order for it to stand out in the competitive field of retail drug sales.
Thanks to the admissions of some of the most influential people in this industry, we are now discovering that much of the research being presented in support of many new drugs, vaccines and procedures is fake, and even leading medical journals are agreeing that big pharma manipulates medical research at the expense of public health.
Consider the following statements and admissions by very important people who are close enough to the inner workings of the industry to know for sure just how bad the public is being deceived.
In 2015, the editor of one of the world’s most respected medical journals, The Lancet, went public with his admission that research fraud was rampant in the field of medical clinical research:
“Much of the scientific literature, perhaps half, may simply be untrue. Afflicted by studies with small sample sizes, tiny effects, invalid exploratory analyses, and flagrant conflicts of interest, together with an obsession for pursuing fashionable trends of dubious importance, science has taken a turn towards darkness.” – Dr. Richard Horton, editor of the world’s most respected medical journal, The Lancet
Furthermore, Dr. Marcia Angell, a physician and longtime Editor-in-Chief of the New England Medical Journal, which is also one of the most prestigious peer-reviewed medical journals in the world, shared a similar opinion:
“It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of the New England Journal of Medicine.” –Dr. Marcia Angell, a physician and longtime Editor-in-Chief of the New England Medical Journal
Public statements like these from some of the world’s most influential medical journals has not triggered any type of official investigation or regulatory response, proving that it is up to consumers to approach this industry with caution.
Even cancer research is being exposed as manipulated, and several prominent physicians have come forth to express their concern that cancer organizations are producing cherry-picked research in order to make their medications or procedures seem like better, safer, and more viable options than they really are.
“Everyone should know that most cancer research is largely a fraud, and that the major cancer research organisations are derelict in their duties to the people who support them.” –Linus Pauling, Ph.D
20 year veteran of the National Cancer Institute and former journal editor, Dr. John Bailer spoke to the American Association for the Advancement of Science and stated:
“My overall assessment is that the national cancer program must be judged a qualified failure. Our whole cancer research in the past 20 years has been a total failure.” –Dr. John Bailer
The following clip is from the documentary ‘One More Girl,’ about the startlingly damaging effects of the Gardasil vaccine. In the clip, former Pfizer Vice President, Dr. Peter Rost candidly discusses the truth about the influence of money in the pharmaceutical industry.
Dr. Rost wrote the book, The Whistleblower, Confessions of a Healthcare Hitman to contribute to the growing body of evidence that blows the whistle on corporate fraud within the medical establishment.
Dependence on so-called clinical research to support the claims made by pharmaceutical marketing departments is proving to be dangerously misled.
Can the public trust the medical establishment to bring effective and safe medicines to market? Increasingly, the evidence is suggesting that it is not.